Tag: CIGX

JVA, CIGX, FBCD – Today’s Hot Stocks

Coffee Holding Co., Inc. JVA

We dont typically talk about listed securities, but are making an exception this morning for JVA. This stock is at a low after having found a bottom in the eight dollar range, and trading at 10.00 or better for the majority of the summer. At times, much better; it hit a high of nearly 30 dollars!

Have a look at the annotated chart we prepared which points out some of the highlights. We have noticed that this stock is capable of making wicked moves; In January it traded in the 4 dollar range, only to hit 30 dollars in July, for over 600% gained. We would love to see that happen again.

Star Scientific, Inc. CIGX

CIGX made a great move this week from a low of 2.00 to a high of 2.84, for a nice 42% gain. The MACD is currently pinching toward a cross, which will signal another bullish rally for CIGX.

Once again we have taken it upon ourselves to include an annotated chart for your viewing convenience which outlines some of the more attractive features of the chart.

Take heed of the gap we pointed out, as gaps like that almost always get filled. After the current run has ended, we will be on the lookout for a retracement to the 2.34-2.41 range.

FBC Holding, Inc. FBCD

Early on this week, we re-added FBCD to our watchlist after a relatively long hiatus. The stock has performed exceptionally well for us in the past, and our confidence that another run is in the cards for the near future is increasing steadily.

We’ve seen an increase in volume over the past couple of weeks that leads us to the conclusion that savvy investors are loading up shares here at this relative bottom. It will be interesting to see where this stock will travel in the coming weeks.

CIGX, FBCD – Today’s Penny Stocks

Star Scientific, Inc. CIGX

One of our past picks, CIGX, is enjoying some momentum today as the stock is currently in the midst of a bounce, which has been extended in part by yesterday’s press. The company highlighted a recent study on the effectiveness of anatabine for treating symptoms of Alzhemiers disease. Anatabine is a primary ingredient in Anatabloc(TM), the dietary supplement developed by CIGX subsidiary, Rock Creek Pharmaceutical.

GLEN ALLEN, Va., Oct. 4, 2011 /PRNewswire via COMTEX/ — Star Scientific, Inc. (Nasdaq: CIGX) reports today the publication of the first peer-reviewed article on the in-vitro and in-vivo activity of anatabine in Alzheimer’s Disease. The article is authored by scientists at the Roskamp Institute and is electronically published in the European Journal of Pharmacology (2011 Sept 19). It states that anatabine lowers Alzheimer’s A-beta production in-vitro and in-vivo.

We always like to keep past plays like this on our radar, as today has proven, you never know when a stock that has performed well in the past is going to provide further opportunities.

FBC Holding, Inc. FBCD

FBCD is another past pick that seemed worthy of mention once again today. For those of you who have followed our activity long enough, you may remember that the first time we talked about this play, was at .015 late last April. By mid-may, it had traded up to .11 for a gain of well over 600% \

We’ve kept an eye on it since then, and have noticed that it had bottomed out at around a penny, and is currently up 20% on the day. This is looking like a good time for us to re-assess our opinion of this stock, after having stood on the sidelines for some time.

————————————————-

Side Note:

We urge our readers to take a look at the Opportunist Magazine Wall Street Journal Edition online, if you would like to receive paper copies by mail, fill out the form on this page. The magazine’s October Edition features our repeat play, Dinewise, Inc. DWIS, and our one-time play, Global Entertainment Holdings GBHL.

VKML Viking Minerals, Inc. & CIGX Star Scientific, Inc. for 09/15

Viking Minerals, Inc. VKML

VKML is a gold play that we mentioned earlier in the Summer, which subsequently made for itself a bottom, moving from .02 to .10, and settling back to its level of .085. We believe that VKML could very well see another 40-50% in gains once the current resistance level of .10 is breached, and the chart certainly looks primed for another surge.

The company recently released positive assay results from its main claim, known as the Dolly Varden property, and at this time we are awaiting further information.

Copper prices are at an all-time high with an overseas demand from Asia which looks to keep prices at these advanced levels or even greater. Copper is one of the most profitable minerals to mine, with the overall profit being around 65%, a margin which is even better than the associated cost of mining gold.

VKML figures to make big strides in the future with expected Copper production reaching more than 10X the average for mines in the area.

PR regarding the assay claim:

PHOENIX, ARIZONA, Sep 06, 2011 (MARKETWIRE via COMTEX) — VIKING MINERALS INC (OTCBB: VKML) ( www.vikingmineralsinc.com) reports up to 5.23% copper from its first five assay results at the Dolly Varden Claims, in Elko County, Nevada.

The five samples were shipped to the ALS Chemex lab in North Vancouver, Canada.

Company President Charles Irizarry stated “The Dolly Varden Property continues to prove it’s self as being highly mineralised with the potential for bulk tonnage copper, gold and silver recovery. The results of up to 5.23% Copper from our first hole have exceeded our expectations. Especially when considering the neighbouring Robinson Mine averages 0.5% Copper. There is growing anticipation on what our next set of results will bring.”

http://www.vikingmineralsinc.com/

Star Scientific, Inc. CIGX

Our original call of CIGX came over a year ago, at which time the stock was trading at 1.55. In the months that followed it had hit a high of 5.35 (On May 31st) marking an enormous gain of 235%

We mentioned CIGX again back on August 31st, when the stock was trading as low as 2.23. Yesterday, the stock hit 3.10, for a gain of 39% and marking the third day in a row of gains.

We had originally called the play as having high rebound potential, and it turns out we were correct. CIGX appeared on the NASDAQ top gainers list this week.

BOCX, CIGX & PASO Inside Today’s Penny Stock Newsletter

Patient Access Solutions, Inc. PASO

Two weeks back, we reported that PASO was trading at its 52-week low, and we felt that the bottom was being solidified in place. Trading on Thursday pushed the price of PASO stock to .0009, which incidentally, could have made savvy traders 50-80% in gains.

As if the increased activity wasn’t enough to be satisfied, the company came with some post-market blockbuster news that could help fuel the continuation of momentum to close out the week strong.

PASO is a perfect example of why patience is key, even with some of our shorter-term plays, just a few weeks time can make a big difference.

HAUPPAUGE, N.Y., Sep 08, 2011 (BUSINESS WIRE) — Patient Access Solutions, Inc. (Pink Sheets: PASO), a leading provider of information technology solutions for the healthcare industry is pleased to announce its EMR management & support solution has been engaged and is being deployed with a Florida based hospital group.

The client is the largest faith based, non profit health care organization in Florida to participate in the EHR (Electronic Health Record) program and has a long standing pedigree as a national leader in the adoption of healthcare IT across its network of 6 hospitals comprising of more than 1,500 beds. This engagement serves as part of its continuing commitment to enable excellent quality care and services, will assist its more than 2,000 physicians in the adoption of Electronic Health Records in their private practices through an EHR Donation Program. The initial implementation expects to generate approximately $3 million in gross revenue over the next year for Patient Access Solutions.

Star Scientific, Inc. CIGX

We were discussing CIGX last Wednesday, at which time the PPS was sitting at 2.33. We alluded to the fact that we believed CIGX qualified as a rebound play. The stock did trade sideways for a few days, and now, over the past two days we have begun to witness some slow and steady gains.

On Thursday, CIGX cracked into the top -gainers list for NASDAQ stocks. It is always impressive when a NASDAQ stock can increase in value 7% in a single day.

Autumn was a huge season for this stock last year, when the PPS doubled in just a few short months. We are anxious to see what activity this fall season will bring to CIGX.

BioCurex, Inc BOCX

Yesterday, BOCX had some earth-shattering news, as the stock price compounded by more than 175%, and this, on forty-four times its 3-month average volume.

When momentum stocks like this hit our radar screen, we like to keep them high on our watchlist as heavy movers with a high bounce probability.

This morning, we foresee a possible gap up followed by a pullback, which we see as a good opportunity to get in for a quick flip on the bounce. Ultimately we will be watching BOCX closely for the dust to settle after yesterday’s excitement.

Here is the huge news that caused all this commotion:

BioCurex’s RECAF(TM) Blood Test for Cancer Can Prevent Two Thirds of Unnecessary Prostate Biopsies

RICHMOND, British Columbia, Sep 8, 2011 (GlobeNewswire via COMTEX) — BioCurex Inc. (OTCBB:BOCX) today announced results indicating that its RECAF blood test for cancer can prevent 70% of unnecessary prostate biopsies.

In a study to be presented at the ISOBM (International Society of Oncology and Biomarkers) annual meeting in October, BioCurex compared the performance of RECAF and free-PSA to discriminate prostate cancer from benign prostate hyperplasia (BPH), a common benign condition that requires no surgical treatment. The RECAF test outperformed the established free-PSA test by approximately 600% in its ability to prevent unnecessary prostate biopsies.

Blue Horseshoe Penny Stock Report, CIGX – 08/31/11

Star Scientific, Inc. CIGX

We wanted take a look at CIGX this morning. This is a Nasdaq play that we have discussed in the distant past. In the past, we have witnessed some stellar gains; one of our subscribers even bought himself a house with his windfall profits from CIGX. As we were browsing our records, we took notice of the recent activity, and felt it was high time to re-open the discussion on this stock.

We noticed a significant drop-off that had recently occurred for CIGX, and believe this should be filed under the “rebound play” category.

The company also had a new PR out this morning.

Aug 31, 2011 (AsiaPulse via COMTEX)

Star Scientific Launches Anatabloc(TM) Dietary Supplement

GLEN ALLEN, Va., Aug. 31, 2011 /PRNewswire-AsiaNet/ —

Star Scientific, Inc. (NASDAQ: CIGX) has announced that the company is pleased to initiate the launch today of Anatabloc(TM), a dietary supplement that is designed to support the immune system in maintaining healthy levels of inflammation.

Anatabloc(TM), developed by the company’s Rock Creek Pharmaceuticals subsidiary, is being launched via a dedicated website (http://www.anatabloc.com) where the product can be purchased. The product also can be purchased through a toll-free customer center (1-800-778-2031).

http://www.bayportcorporation.com/

Get Our FREE Daily Reports!

SUBSCRIBE